News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
173,480 Results
Type
Article (9411)
Company Profile (33)
Press Release (164036)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (51779)
Career Advice (265)
Deals (8179)
Drug Delivery (10)
Drug Development (13083)
Employer Resources (20)
FDA (4805)
Job Trends (4000)
News (80627)
Policy (7756)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (891)
Academic (1)
Allergies (20)
Alliances (16866)
ALS (10)
Alzheimer's disease (411)
Antibody-drug conjugate (ADC) (21)
Approvals (4855)
Artificial intelligence (108)
Autoimmune disease (1)
Automation (9)
Bankruptcy (61)
Best Places to Work (3125)
BIOSECURE Act (2)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (21)
Brain cancer (9)
Breast cancer (94)
Cancer (653)
Cardiovascular disease (43)
Career advice (242)
Career pathing (2)
CAR-T (25)
Cell therapy (63)
Cervical cancer (11)
Clinical research (10235)
Collaboration (270)
Compensation (17)
Complete response letters (3)
COVID-19 (815)
CRISPR (5)
C-suite (51)
Cystic fibrosis (15)
Data (481)
Decentralized trials (1)
Depression (7)
Diabetes (35)
Diagnostics (6086)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (29)
Drug pricing (4)
Drug shortages (2)
Duchenne muscular dystrophy (13)
Earnings (15993)
Employer branding (5)
Employer resources (18)
Events (20022)
Executive appointments (179)
FDA (5105)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (184)
Gene editing (9)
Generative AI (10)
Gene therapy (49)
GLP-1 (122)
Government (1235)
Grass and pollen (3)
Guidances (10)
Healthcare (4282)
IgA nephropathy (1)
Immunology and inflammation (9)
Indications (6)
Infectious disease (858)
Inflammatory bowel disease (18)
Influenza (18)
Intellectual property (18)
Interviews (30)
IPO (2708)
IRA (1)
Job creations (1005)
Job search strategy (231)
Kidney cancer (6)
Labor market (2)
Layoffs (47)
Leadership (2)
Legal (1475)
Liver cancer (15)
Lung cancer (93)
Lymphoma (48)
Machine learning (3)
Management (5)
Manufacturing (82)
MASH (8)
Medical device (3066)
Medtech (3066)
Mergers & acquisitions (5595)
Metabolic disorders (72)
Multiple sclerosis (24)
NASH (4)
Neurodegenerative disease (19)
Neuropsychiatric disorders (2)
Neuroscience (499)
NextGen: Class of 2025 (1245)
Non-profit (954)
Northern California (511)
Now hiring (11)
Obesity (30)
Opinion (22)
Ovarian cancer (16)
Pain (9)
Pancreatic cancer (13)
Parkinson's disease (26)
Partnered (7)
Patents (37)
Patient recruitment (15)
Peanut (12)
People (15475)
Pharmaceutical (7)
Phase I (3034)
Phase II (4033)
Phase III (3921)
Pipeline (242)
Policy (6)
Postmarket research (529)
Preclinical (1609)
Press Release (23)
Prostate cancer (47)
Psychedelics (3)
Radiopharmaceuticals (131)
Rare diseases (57)
Real estate (2422)
Recruiting (8)
Regulatory (5546)
Reports (13)
Research institute (895)
Resumes & cover letters (30)
Rett syndrome (1)
RSV (4)
Schizophrenia (1)
Series A (25)
Series B (16)
Service/supplier (2)
Sickle cell disease (5)
Southern California (436)
Spinal muscular atrophy (42)
Sponsored (9)
Startups (1064)
State (1)
Stomach cancer (4)
Supply chain (14)
Tariffs (1)
The Weekly (2)
United States (4858)
Vaccines (89)
Venture capitalists (7)
Weight loss (15)
Women's health (8)
Date
Today (31)
Last 7 days (174)
Last 30 days (556)
Last 365 days (7311)
2025 (2352)
2024 (7808)
2023 (9234)
2022 (14733)
2021 (14924)
2020 (14170)
2019 (10184)
2018 (7934)
2017 (8706)
2016 (8804)
2015 (9860)
2014 (7897)
2013 (7048)
2012 (7408)
2011 (7601)
2010 (6800)
Location
Africa (209)
Alabama (11)
Alaska (2)
Arizona (73)
Arkansas (4)
Asia (10118)
Australia (1988)
California (1153)
Canada (437)
China (58)
Colorado (76)
Connecticut (77)
Delaware (31)
Europe (24050)
Florida (152)
Georgia (46)
Idaho (8)
Illinois (125)
India (7)
Indiana (67)
Iowa (4)
Japan (41)
Kansas (27)
Kentucky (6)
Louisiana (2)
Maine (25)
Maryland (166)
Massachusetts (670)
Michigan (116)
Minnesota (90)
Missouri (48)
Montana (12)
Nebraska (8)
Nevada (4)
New Hampshire (19)
New Jersey (363)
New Mexico (19)
New York (470)
North Carolina (266)
North Dakota (6)
Northern California (511)
Ohio (60)
Oklahoma (4)
Oregon (7)
Pennsylvania (159)
Rhode Island (12)
South America (270)
South Carolina (7)
Southern California (436)
Tennessee (46)
Texas (251)
Utah (95)
Virginia (44)
Washington D.C. (10)
Washington State (129)
Wisconsin (31)
173,480 Results for "clearpoint diagnostics laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
April 29, 2025
·
4 min read
Press Releases
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025
April 25, 2025
·
4 min read
Press Releases
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
January 27, 2025
·
5 min read
Press Releases
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results
February 26, 2025
·
11 min read
Press Releases
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
February 12, 2025
·
5 min read
Biotech Beach
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
ClearPoint Neuro, Inc. congratulates its partner Aspen Neuroscience, Inc. on use of the ClearPoint Neuro Navigation System to transplant dopaminergic neuron precursor cells for all enrolled patients with Parkinson’s Disease in its recently launched ASPIRO Phase 1/2a clinical trial.
June 20, 2024
·
6 min read
Biotech Beach
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
ClearPoint Neuro, Inc. announces full market release of its SmartFrame OR platform and ClearPoint Prism Neuro Laser Therapy System at the 2024 Biennial Meeting of the American Society of Stereotactic and Functional Neurosurgery from Saturday, June 1st – Tuesday, June 4th in Nashville.
June 1, 2024
·
5 min read
Press Releases
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
February 17, 2025
·
4 min read
FDA
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
ClearPoint Neuro, Inc. today announced it has received 510(k) clearance for its Prism Bone Anchor Accessory.
April 29, 2024
·
4 min read
Business
ClearPoint Neuro Reports First Quarter 2024 Results
ClearPoint Neuro, Inc., a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announced financial results for its first quarter ended March 31, 2024.
May 7, 2024
·
12 min read
1 of 17,348
Next
